Table 2.
Intervention in included studies.
| First author, year | Intervention | Control |
|---|---|---|
| Bai SR, 2016 | Bai Ling Capsule: Dong Chong Xia Cao, 3 capsules, tid; Bu Fei Huo Xue Capsule, 4 Capsules, tid; Salmeterol/fluticasone, 50/250 ug, bid; or add aminophylline, 0.1 g, bid; Oxygen therapy | Salmeterol/fluticasone, 50/250 ug, bid; or add aminophylline, 0.1 g, bid; Oxygen therapy |
|
| ||
| Cao DC, 2016 | Bai Ling Capsule: Dong Chong Xia Cao, 5 capsules, tid; routine care | Routine care∗ |
|
| ||
| Dong KZ, 2016 | He Che Chong Cao Capsule: Dong Chong Xia Cao, Zi He Che, Hong Shen, San Qi, Ge Jie, Lu Jiao Shuang, Bei Mu, 4 Capsules, tid; budesonide/formoterol, 60 ug/4.5 ug, bid | Budesonide/formoterol,60 ug/4.5 ug, Bid |
|
| ||
| Fei DL, 2010 | Jin Shui Bao Capsule: Dong Chong Xia Cao; routine care | Routine care |
|
| ||
| He WJ, 2010 | Bai Ling Capsule: Dong Chong Xia Cao, 4 capsules, tid; Shan Yu Rou, Yin Yang Huo, Wu Wei Zi, Tai Zi Shen, Bai Guo, Fu Ling, Dan Shen; routine care | Routine care |
|
| ||
| Hu QG, 2012 | Jin Shui Bao Capsule:Dong Chong Xia Cao, 3 capsules, tid; Bu Fei Huo Xue Capsule, 4 Capsules, tid; Oxygen therapy, if AECOPD: antibiotics, aminophylline, anticholinergic, ICS | Oxygen therapy, if AECOPD: antibiotics, aminophylline, anticholinergic, ICS |
|
| ||
| Huang DH, 2005 | Bai Ling Capsule: Dong Chong Xia Cao, 5 capsules, tid; Yu Ping Feng Powder: Huang Qi, Bai Zhu, Fang Feng, 5 g, tid; Jian Pi Yi Fei Powder: Ren Shen, Bai Zhu, Fu Ling, Mai Dong, Sang Bai Pi, Huang Qi, 10g, tid; routine care | Routine care |
|
| ||
| Liu JS, 2014 | Jin Shui Bao Capsule:Dong Chong Xia Cao, 3 capsules, tid; Yu Ping Feng Powder: Huang Qi, Bai Zhu, Fang Feng, 6 g, tid; routine care | Routine care |
|
| ||
| Luo SW, 2015 | Bai Ling Capsule: Dong Chong Xia Cao, 5 capsules, tid; routine care | Routine care |
|
| ||
| Tang CY, 2009 | Bai Ling Capsule: Dong Chong Xia Cao, 3 capsules, tid; routine care | Routine care |
|
| ||
| Wu HL, 2016 | Bai Ling Capsule: Dong Chong Xia Cao, 5 capsules, tid; routine care | Routine care |
|
| ||
| Xin DY, 2015 | Li Fei tablet: Dong Chong Xia Cao, Ge Jie, Wu Wei Zi, Bai He, Bai Bu, Gan Cao, Pi Pa Ye, Bai Ji, etc., 2 tablets, tid; aminophylline, 0.2 g, bid; Ambroxol hydrochloride, 30 mg, tid. | Aminophylline, 0.2 g, bid; Ambroxol hydrochloride, 30 mg, tid. |
|
| ||
| Yao JF, 2013 | Dong Chong Xia Cao, Huang Qi, Hong Jing Tian, Yin Xing, Gua Lou, Hai Ge Qiao, Shui Zhi, Ma Huang; Salmeterol/fluticasone, 50/250 ug, bid; aminophylline, 0.1 g, bid | Salmeterol/fluticasone, 50/250 ug, bid; aminophylline, 0.1 g, bid |
|
| ||
| Zhou Y, 2014 | Bai Ling Capsule: Dong Chong Xia Cao, 5 capsules, tid; routine care; salmeterol/fluticasone, 50/250 ug, bid | Routine care; salmeterol/fluticasone, 50/250ug, bid |
∗The treatments follow therapeutic principle in gidelines, but the interventions may be different base on patients' conditions.